David Noble - Star Equity Chief Officer
| STRR Stock | USD 2.48 0.15 5.70% |
Insider
David Noble is Chief Officer of Star Equity Holdings
| Age | 54 |
| Address | 53 Forest Avenue, Old Greenwich, CT, United States, 06870 |
| Phone | 203 489 9500 |
| Web | https://www.starequity.com |
David Noble Latest Insider Activity
Tracking and analyzing the buying and selling activities of David Noble against Star Equity stock is an integral part of due diligence when investing in Star Equity. David Noble insider activity provides valuable insight into whether Star Equity is net buyers or sellers over its current business cycle. Note, Star Equity insiders must abide by specific rules, including filing SEC forms every time they buy or sell Star Equity'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
David Noble over three months ago Disposition of 1667 shares by David Noble of Star Equity subject to Rule 16b-3 | ||
David Noble over three months ago Disposition of 3414 shares by David Noble of Star Equity subject to Rule 16b-3 | ||
David Noble over six months ago Disposition of 3311 shares by David Noble of Star Equity subject to Rule 16b-3 |
Star Equity Management Efficiency
The company has return on total asset (ROA) of (0.0735) % which means that it has lost $0.0735 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1047) %, meaning that it created substantial loss on money invested by shareholders. Star Equity's management efficiency ratios could be used to measure how well Star Equity manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Star Equity's Return On Tangible Assets are relatively stable compared to the past year. As of 12/16/2024, Return On Assets is likely to grow to 0.35, while Return On Capital Employed is likely to drop (0.07). At this time, Star Equity's Asset Turnover is relatively stable compared to the past year.Similar Executives
| Showing other executives | INSIDER Age | ||
| Richard Heyman | Syndax Pharmaceuticals | 67 | |
| Anjali Ganguli | Syndax Pharmaceuticals | 47 | |
| Peter BSc | Syndax Pharmaceuticals | 55 | |
| Adam Levy | Zentalis Pharmaceuticals Llc | N/A | |
| Briggs MD | Syndax Pharmaceuticals | 64 | |
| Meena Rao | Zentalis Pharmaceuticals Llc | N/A | |
| Madan Jagasia | Iovance Biotherapeutics | N/A | |
| Carrie MD | Zentalis Pharmaceuticals Llc | 54 | |
| Alexander Nolte | Syndax Pharmaceuticals | 51 | |
| Ronald Evans | Syndax Pharmaceuticals | 75 | |
| Esq JD | Iovance Biotherapeutics | 48 | |
| Mark Lackner | Zentalis Pharmaceuticals Llc | 56 | |
| Michael MBA | Syndax Pharmaceuticals | 53 | |
| Friedrich MD | Iovance Biotherapeutics | 57 | |
| Kevin Bunker | Zentalis Pharmaceuticals Llc | 52 | |
| Jeffrey Ludwig | Puma Biotechnology | 58 | |
| Howard MBA | Iovance Biotherapeutics | 64 | |
| Igor Bilinsky | Iovance Biotherapeutics | 51 | |
| Melissa MBA | Zentalis Pharmaceuticals Llc | 45 | |
| JeanMarc MBA | Iovance Biotherapeutics | 52 | |
| Kimberly MD | Zentalis Pharmaceuticals Llc | 55 | |
Management Performance
| Return On Equity | -0.1 | ||||
| Return On Asset | -0.0735 |
Star Equity Holdings Leadership Team
Elected by the shareholders, the Star Equity's board of directors comprises two types of representatives: Star Equity inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Star. The board's role is to monitor Star Equity's management team and ensure that shareholders' interests are well served. Star Equity's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Star Equity's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jeffrey Eberwein, Executive Board | ||
| Bob Halbert, Director Resource | ||
| Martin Shirley, Pres Solutions | ||
| Matthew Molchan, I Health | ||
| CCP CEBS, Senior Resource | ||
| Hannah Bible, Chief Officer | ||
| Scott Jarchow, I EdgeBuilder | ||
| Richard Coleman, CEO Director | ||
| Thatcher Butcher, President Inc | ||
| David Noble, Chief Officer |
Star Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Star Equity a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.1 | ||||
| Return On Asset | -0.0735 | ||||
| Profit Margin | (0.15) % | ||||
| Operating Margin | (0.28) % | ||||
| Current Valuation | 39.7 M | ||||
| Shares Outstanding | 3.22 M | ||||
| Shares Owned By Insiders | 28.92 % | ||||
| Shares Owned By Institutions | 8.60 % | ||||
| Number Of Shares Shorted | 25.41 K | ||||
| Price To Book | 0.23 X |
Pair Trading with Star Equity
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Star Equity position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Star Equity will appreciate offsetting losses from the drop in the long position's value.Moving together with Star Stock
Moving against Star Stock
| 0.86 | BMY | Bristol Myers Squibb | PairCorr |
| 0.82 | ESPR | Esperion Therapeutics | PairCorr |
| 0.77 | DYAI | Dyadic International | PairCorr |
| 0.76 | GILD | Gilead Sciences | PairCorr |
| 0.44 | DNA | Ginkgo Bioworks Holdings Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Star Equity could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Star Equity when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Star Equity - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Star Equity Holdings to buy it.
The correlation of Star Equity is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Star Equity moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Star Equity Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Star Equity can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Star Stock Analysis
When running Star Equity's price analysis, check to measure Star Equity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Star Equity is operating at the current time. Most of Star Equity's value examination focuses on studying past and present price action to predict the probability of Star Equity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Star Equity's price. Additionally, you may evaluate how the addition of Star Equity to your portfolios can decrease your overall portfolio volatility.